Introduction: PCSK9i & LDL-c - Guidelines, Practice & Innovation

Media formats available:

Time to reduce implementation gaps of lipid-lowering therapy
Time to reduce implementation gaps of lipid-lowering therapy
PCSK9i & LDL-c: Guidelines, Practice & Innovation: Review of facts and opportunities
Time to reduce implementation gaps of lipid-lowering therapy
- Prof Kausik Ray
Five years of PCSK9i - Lessons from practice: Which patients benefit most?
Five years of PCSK9i - Lessons from practice: Which patients benefit most?
PCSK9i & LDL-c: Guidelines, Practice & Innovation: Review of facts and opportunities
Five years of PCSK9i - Lessons from practice: Which patients benefit most?
- Prof. Erik Stroes, MD
One year after the new ESC/EAS dyslipidemia guidelines
One year after the new ESC/EAS dyslipidemia guidelines
PCSK9i & LDL-c: Guidelines, Practice & Innovation: Review of facts and opportunities
One year after the new ESC/EAS dyslipidemia guidelines
- Prof. François Mach, MD

PACE-CME